| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |